"Designing Growth Strategies is in our DNA"

Multiple Sclerosis Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Immunomodulators, Immunosuppressants, Interferons, and Others), By Route of Administration (Oral and Injection (Intramuscular, Subcutaneous, and Intravenous)), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Forecast, 2022-2029

Region : Global | Format: PDF | Report ID: FBI100386

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Request for Customization

Refresh Button
Booklet
  • May, 2022
  • 2021
  • 2018-2020
  • 160

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X